EFFICACY OF A NOVEL ANTIBODY-DRUG CONJUGATE (ADC), ABT-414, AS MONOTHERAPY IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (EGFRAMP), RECURRENT GLIOBLASTOMA (RGBM) Conference Paper uri icon

authors

  • van den Bent, M
  • Gan, H
  • Lassman, A
  • Kumthekar, P
  • Butowski, N
  • Nabors, L
  • Simes, J
  • Maag, D
  • Reardon, D

publication date

  • May 1, 2017